Biohaven Pharmaceutical Holding Stock Price Prediction
| BHVN Stock | USD 43.68 1.06 2.37% |
Oversold Vs Overbought
38
Oversold | Overbought |
EPS Estimate Next Quarter (1.61) | EPS Estimate Current Year (8.62) | EPS Estimate Next Year (5.92) | Wall Street Target Price 65.0714 | EPS Estimate Current Quarter (1.70) |
Using Biohaven Pharmaceutical hype-based prediction, you can estimate the value of Biohaven Pharmaceutical Holding from the perspective of Biohaven Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
Biohaven Pharmaceutical Hype to Price Pattern
Investor biases related to Biohaven Pharmaceutical's public news can be used to forecast risks associated with an investment in Biohaven. The trend in average sentiment can be used to explain how an investor holding Biohaven can time the market purely based on public headlines and social activities around Biohaven Pharmaceutical Holding. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Biohaven Pharmaceutical's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Biohaven Pharmaceutical.
The fear of missing out, i.e., FOMO, can cause potential investors in Biohaven Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Biohaven because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Biohaven Pharmaceutical after-hype prediction price | USD 45.76 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Biohaven |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biohaven Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biohaven Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Biohaven Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biohaven Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biohaven Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biohaven Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Biohaven Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biohaven Pharmaceutical's historical news coverage. Biohaven Pharmaceutical's after-hype downside and upside margins for the prediction period are 42.22 and 49.30, respectively. We have considered Biohaven Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biohaven Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Biohaven Pharmaceutical is based on 3 months time horizon.
Biohaven Pharmaceutical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Biohaven Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biohaven Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biohaven Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.37 | 3.54 | 0.25 | 0.08 | 10 Events / Month | 15 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
43.68 | 45.76 | 0.54 |
|
Biohaven Pharmaceutical Hype Timeline
Biohaven Pharmaceutical is currently traded for 43.68. The entity has historical hype elasticity of -0.25, and average elasticity to hype of competition of 0.08. Biohaven is anticipated to decline in value after the next headline, with the price expected to drop to 45.76. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.54%, whereas the daily expected return is currently at 0.37%. The volatility of related hype on Biohaven Pharmaceutical is about 1702.78%, with the expected price after the next announcement by competition of 43.76. About 87.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 9.37. Biohaven Pharmaceutical had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Biohaven Pharmaceutical Basic Forecasting Models to cross-verify your projections.Biohaven Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Biohaven Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Biohaven Pharmaceutical's future price movements. Getting to know how Biohaven Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biohaven Pharmaceutical may potentially react to the hype associated with one of its peers.
Biohaven Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Biohaven price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biohaven using various technical indicators. When you analyze Biohaven charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biohaven Pharmaceutical Predictive Indicators
The successful prediction of Biohaven Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biohaven Pharmaceutical Holding, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biohaven Pharmaceutical based on analysis of Biohaven Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biohaven Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biohaven Pharmaceutical's related companies. | 2023 | 2024 (projected) | Graham Number | 27.84 | 17.61 | Receivables Turnover | 42.0 | 37.34 |
Story Coverage note for Biohaven Pharmaceutical
The number of cover stories for Biohaven Pharmaceutical depends on current market conditions and Biohaven Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biohaven Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biohaven Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Biohaven Pharmaceutical Short Properties
Biohaven Pharmaceutical's future price predictability will typically decrease when Biohaven Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biohaven Pharmaceutical Holding often depends not only on the future outlook of the potential Biohaven Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biohaven Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 71.2 M | |
| Cash And Short Term Investments | 381.8 M |
Check out Biohaven Pharmaceutical Basic Forecasting Models to cross-verify your projections. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.37) | Return On Assets (1.19) | Return On Equity (2.65) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.